002755 Beijing Aosaikang Pharmaceutical
- 13.33
- +0.05+0.38%
Beijing Aosaikang Pharmaceutical News
Osaicom: Announcement on shareholders holding 5% or more of the shares prematurely terminating the holdings reduction plan
Osecon: Announcement on shareholders holding 5% or more of the shares to reduce their shareholding to 1%
Osecon: Pre-disclosure announcement on the expiration of the holdings reduction plan for shareholders holding 5% or more of the shares and the new phase of the holdings reduction plan
Osecon: Pre-disclosure announcement on plans for shareholders holding 5% or more of the shares to reduce their holdings
Osecon: Announcement on the progress of shareholders holding 5% or more of the shareholding plan to reduce their holdings by more than half of the planned period
Osecon: Pre-disclosure announcement on the expiration of the holdings reduction plan for shareholders holding 5% or more of the shares and the new phase of the holdings reduction plan
Osecon: Announcement on the progress of shareholders holding 5% or more of the shareholding plan to reduce their holdings by more than half of the planned period
Osecon: Pre-disclosure announcement on the expiration of the holdings reduction plan for shareholders holding 5% or more of the shares and the new phase of the holdings reduction plan
Osecon: Announcement on the progress of shareholders holding 5% or more of their shares in reducing their holdings by more than half of the time
Osecon: Progress Announcement on Issuance of Shares and Payment of Cash to Purchase Assets
Osecon: Huatai United Securities Co., Ltd.'s 2021 Continued Supervision Opinions and Continued Supervision Summary Report on Beijing Aosaikang Pharmaceutical Co., Ltd.'s Major Asset Exchange and Issuance of Shares to Purchase Assets and Related Transaction
Osekon: 2021 Profit Distribution Plan Announcement
Osecon: Pre-disclosure announcement on plans for shareholders holding 5% or more of the shares to reduce their holdings
Osecon: Progress Announcement on Issuance of Shares and Payment of Cash to Purchase Assets
Osecon: Progress Announcement on Issuance of Shares and Payment of Cash to Purchase Assets
Osecon: Prompt announcement on the listing and circulation of some restricted shares
Osecon: Progress Announcement on Issuance of Shares and Payment of Cash to Purchase Assets
Osecon: Notice on receipt of the China Securities Regulatory Commission's decision not to approve the company's application to issue shares and pay cash to purchase assets
Osecon: Announcement on the issuance of shares and payment of cash to purchase assets that were not reviewed and approved by the China Securities Regulatory Commission\'s M&A and restructuring review committee and that the company\'s stock trading resumed
Osecon: Beijing Aosaikang Pharmaceutical Co., Ltd. issued shares and paid cash to purchase assets transaction report (draft) (second revised draft)
Analysis
Price Target
No Data
No Data